
HTG Molecular Diagnostics HTGM
Annual report 2022
added 03-30-2023
HTG Molecular Diagnostics Operating Cash Flow 2011-2025 | HTGM
Annual Operating Cash Flow HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.4 M | -16.5 M | -16.3 M | -16.7 M | -13.2 M | -16.6 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -13.2 M | -18.4 M | -16.3 M |
Quarterly Operating Cash Flow HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -16.4 M | -11.8 M | -5.94 M | - | -13.1 M | -8.9 M | -4.35 M | - | -12.7 M | -8.38 M | -3.93 M | - | -12.8 M | -8.77 M | -5.59 M | - | -10.6 M | -7.01 M | -2.7 M | - | -13.7 M | -9.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -2.7 M | -16.4 M | -9.2 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
884 K | $ 19.0 | -1.91 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 20.7 | -2.24 % | $ 223 M | ||
|
Co-Diagnostics
CODX
|
-22.1 M | $ 0.23 | -3.87 % | $ 6.75 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 39.2 | -0.51 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
6.69 B | $ 230.43 | 0.05 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
-30.4 M | $ 10.56 | 5.18 % | $ 300 M | ||
|
BioNano Genomics
BNGO
|
-68.9 M | $ 1.51 | -0.95 % | $ 1.92 M | ||
|
Exact Sciences Corporation
EXAS
|
211 M | $ 101.85 | 0.28 % | $ 18.9 B | ||
|
DexCom
DXCM
|
748 M | $ 67.71 | 0.21 % | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 26.63 | -0.34 % | $ 805 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-18.4 M | $ 19.04 | -2.26 % | $ 1.02 B | ||
|
Celcuity
CELC
|
-83.5 M | $ 101.24 | -0.99 % | $ 3.99 B | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-7.34 M | $ 3.19 | -0.47 % | $ 102 K | ||
|
IQVIA Holdings
IQV
|
2.72 B | $ 226.71 | -0.09 % | $ 41.1 B | ||
|
Guardant Health
GH
|
-240 M | $ 101.95 | -1.01 % | $ 12.5 B | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 7.23 | 1.4 % | $ 1.57 B | ||
|
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
-8.7 M | $ 6.35 | -2.01 % | $ 575 M | ||
|
National Research Corporation
NRC
|
38.1 M | $ 18.92 | 1.39 % | $ 464 M | ||
|
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 4.81 | -5.39 % | $ 2.58 M | ||
|
Personalis
PSNL
|
-45.2 M | $ 8.05 | -1.11 % | $ 477 M | ||
|
Illumina
ILMN
|
837 M | $ 133.97 | -0.73 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
735 M | $ 203.01 | -0.32 % | $ 10.4 B | ||
|
RadNet
RDNT
|
233 M | $ 73.05 | -0.14 % | $ 5.34 B | ||
|
Soleno Therapeutics
SLNO
|
-69.1 M | $ 47.74 | 0.19 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.33 B | $ 175.29 | -0.37 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
-48.6 M | $ 6.73 | -1.32 % | $ 873 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
1.59 B | $ 252.89 | -0.39 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 182.85 | 0.01 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
929 M | $ 683.4 | -0.74 % | $ 56.4 B | ||
|
Lantheus Holdings
LNTH
|
545 M | $ 67.01 | 0.45 % | $ 4.64 B | ||
|
Mettler-Toledo International
MTD
|
968 M | $ 1 413.2 | -0.49 % | $ 30 B |